293e54796f022ba8…

{
  "id": "NCT00105547",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of the study is to evaluate the change in cognitive ability and activities of daily living in patients with Alzheimer's disease (AD) as measured by specific evaluations during 18 months of dosing.",
    "completionDate": "2008-05",
    "conditions": [
      "Alzheimer Disease",
      "Dementia"
    ],
    "enrollmentCount": 1600,
    "enrollmentType": "ACTUAL",
    "nctId": "NCT00105547",
    "phase": "PHASE3",
    "sponsorId": "myrexis-inc",
    "startDate": "2005-02",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Study of the Effect of Daily Treatment With MPC-7869 on Measures of Cognition, Activities of Daily Living and Global Function in Subjects With Mild Dementia of the Alzheimer's Type",
    "url": "https://clinicaltrials.gov/study/NCT00105547"
  }
}